Equities

Sichuan Huiyu Pharmaceutical Co Ltd

688553:SHH

Sichuan Huiyu Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)10.21
  • Today's Change0.14 / 1.39%
  • Shares traded604.87k
  • 1 Year change-30.31%
  • Beta--
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,4192,5822,955
Total Receivables, Net1258741
Total Inventory153166179
Prepaid expenses203345
Other current assets, total1525.4613
Total current assets2,8702,8733,233
Property, plant & equipment, net1,4711,209767
Goodwill, net------
Intangibles, net786464
Long term investments2109954
Note receivable - long term------
Other long term assets------
Total assets4,6864,2774,130
LIABILITIES
Accounts payable1309659
Accrued expenses454846
Notes payable/short-term debt4314514
Current portion long-term debt/capital leases2.855.433.06
Other current liabilities, total271332371
Total current liabilities879526493
Total long term debt2.054.623.28
Total debt4365520
Deferred income tax5.545.270.60
Minority interest3.83----
Other liabilities, total242274
Total liabilities915558571
SHAREHOLDERS EQUITY
Common stock424424424
Additional paid-in capital2,4852,4742,473
Retained earnings (accumulated deficit)871831671
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(9.15)(9.63)(9.41)
Total equity3,7713,7183,558
Total liabilities & shareholders' equity4,6864,2774,130
Total common shares outstanding424424424
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.